Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Abu Saadeh

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
QJM : Monthly Journal of the Association of Physicians|March 8, 2021
Pelvic actinomycosisR Floyd, S Hunter, F Abu Saadeh, et al.
Thrombosis Research|May 11, 2016
OC-12 - Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practiceS Petch, L A Norris, S A O'Toole, et al.
Thrombosis Research|May 11, 2016
PO-24 - Determinants of thrombin generation in gynaecological malignanciesL A Norris, F A Martin, S A O'Toole, et al.
Thrombosis Research|September 16, 2021
Extended thromboprophylaxis post gynaecological cancer surgery; the effect of weight adjusted and fixed dose LMWH (Tinzaparin)F Abu Saadeh, Z Marchocki, S A O'Toole, et al.
Thrombosis Research|May 11, 2016
PO-14 - Tumour expression of coagulation proteases of the aPC pathway - a role in the pathogenesis of gynaecological cancers?F Martin, J C Long, S A O'Toole, et al.
Thrombosis Research|January 10, 2025
Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosisM P Ward, E M Ibrahim, S A O'Toole, et al.
Thrombosis Research|February 27, 2016
Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapyF Abu Saadeh, R Langhe, D M Galvin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
QJM : Monthly Journal of the Association of Physicians|March 8, 2021
Pelvic actinomycosisR Floyd, S Hunter, F Abu Saadeh, et al.
Thrombosis Research|May 11, 2016
OC-12 - Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practiceS Petch, L A Norris, S A O'Toole, et al.
Thrombosis Research|May 11, 2016
PO-24 - Determinants of thrombin generation in gynaecological malignanciesL A Norris, F A Martin, S A O'Toole, et al.
Thrombosis Research|September 16, 2021
Extended thromboprophylaxis post gynaecological cancer surgery; the effect of weight adjusted and fixed dose LMWH (Tinzaparin)F Abu Saadeh, Z Marchocki, S A O'Toole, et al.
Thrombosis Research|May 11, 2016
PO-14 - Tumour expression of coagulation proteases of the aPC pathway - a role in the pathogenesis of gynaecological cancers?F Martin, J C Long, S A O'Toole, et al.
Thrombosis Research|January 10, 2025
Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosisM P Ward, E M Ibrahim, S A O'Toole, et al.
Thrombosis Research|February 27, 2016
Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapyF Abu Saadeh, R Langhe, D M Galvin, et al.
Pageof 1